Abstract
Apolipoprotein H (apoH, protein; APOH, gene) has been implicated as a necessary cofactor for the binding of certain autoimmune antiphospholipid antibodies to anionic phospholipids. APOH exhibits genetically determined structural polymorphism with the occurrence of four alleles. Recently three IgG1k monoclonal antibodies (mAb) to human apoH, designated 3G9, 1B4, and 3D11, have been produced. The mAb 3D11 does not recognize apoH bound to anionic phospholipids in contrast to mAb 3G9 and 1B4, which recognize free and phospholipid-bound apoH. In this investigation we have determined the reactivity of the three mAb with four APOH allele products and the binding ability of these allele products with anionic phospholipids. The mAb 3G9 and 1B4, like the polyclonal anti-apoH, were equally reactive with all four allelic products, but the 3D11 recognized only the APOH *3 allele product. In the 159 APOH *3 carriers tested from five ethnic groups, the reactivity of mAb 3D11 was observed with all the Chinese but none of the African blacks. For the U.S. whites and Polynesians 89% and 75%, respectively, of the APOH *3 allele products were recognized by 3D11, while 87% of the U.S. blacks with this allele had no 3D11 reactivity. These data show that the APOH *3 allele, originally identified as a single entity by the polyclonal anti-apoH, is heterogeneous with at least one distinct variation based on mAb 3D11 reactivity. Our data also demonstrate that the apoH from certain homozygous APOH *3 individuals is unable to bind to anionic phospholipids. Such ethnic-specific apoH variations could play a significant role in the binding properties of autoimmune antiphospholipid antibodies to anionic phospholipids.
Similar content being viewed by others
References
Bancsi LFJMM, VanderLinden IK, and Bertina RM (1992) β2Glycoprotein I deficiency and the risk of thrombosis. Thromb Haemost 67:649–653
Chakraborty R, Kamboh MI, Nwankwo M. Ferrell RE (1992) Caucasian genes in the American blacks. Am J Hum Genet 50:145–150
Cleve H (1968) Genetic studies on the deficiency of β2-glycoprotein I of human serum. Humangenetik 5: 294–304
Cleve H, Vogt U, Kamboh MI (1992) Genetic polymorphism of apolipoprotein H (β2-glycoprotein I) in African blacks from the Ivory Coast. Electrophoresis 13: 849–851
Crews DE, Kamboh MI, Bindon JR, Ferrell RE (1991) Genetic studies of human apolipoproteins. XVII. Population genetics of apolipoprotein polymorphisms in American Samoa. Am J Phys Anthropol 84:165–170
Galli M, Comfurius P, Maassen C, Hemker HC, Debaets MH, Van Brenda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1:1544–1547
Galli M, Comfurius P, Barbui T, Zwaal RRA, Bevers EM (1992) Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 68:297–300
Heimburger N, Heide K, Haupt H, Schultze HE (1964) Baustein-analysen von human Serum Proteinen. Clin Chim Acta 10:293–302
Jones JV, James H, Tann MH, Mansour M (1992) Antiphospholipid antibodies require β2-glycoprotein I (apolipoprotein H) as cofactor. J Rheumatol 19:1397–1402
Kamboh MI, Ferrell RE (1991) Apolipoprotein H polymorphism and its role in lipid metabolism. Adv Lipid Res 1:9–18
Kamboh MI, Ferrell RE, Sepehrnia B (1988) Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (β2-glycoprotein I). Am J Hum Genet 42:452–457
McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120–4124
Nimpf J, Bevers EM, Bomans HH, Till U, Wurm H, Kostner GM, Zwall RFA (1986) Prothrombinase activity of human platelets is inhibited by β2-glycoprotein. I. Biochim Biophys Acta 884:142–149
Nimpf J, Wurm H, Kostner GM (1987) β2-Glycoprotein I (apoH) inhibits the release reaction of human during ADP-induced aggregation. Atherosclerosis 63: 109–114
Oosting J, Derksen R, Entjes H, Bouma B, Groot P (1992) Lupus anticoagulant activity is frequently dependent on the presence of β2-glycoprotein I. Thromb Haemost 67:499–502
Saha N, Kamboh MI, Kelly LJ, Ferrell RE, Tay JSH (1992) Apolipoprotein H (beta-2-glycoprotein I) polymorphism in Asians. Hum Biol 64:617–621
Schousboe I (1980) Binding of β2-glycoprotein I to platelets: effect on adenylate cyclase activity. Thromb Res 19:225–237
Schousboe I (1985) β2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66:1086–1091
Wagenknecht DR, McIntyre JA (1993) Changes in β2-glycoprotein I antigenicity induced by phospholipid binding. Thromb Haemost 69:361–365
Wurm H, Beubler E, Polze E, Holasek A, Kostner G (1982) Studies on the possible function of β2-glycoprotein I: influence in the triglyceride metabolism in rat. Metabolism 32:484–486
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamboh, M.I., Wagenknecht, D.R. & McIntyre, J.A. Heterogeneity of the apolipoprotein H *3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipids. Hum Genet 95, 385–388 (1995). https://doi.org/10.1007/BF00208960
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00208960